On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy - PubMed (original) (raw)
- PMID: 14572113
Editorial
On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy
Emmanuel Mignot et al. Sleep. 2003 Sep.
Erratum in
- Sleep. 2003 Nov 1;26(7):784
No abstract available
Comment on
- Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.
Kubota H, Kanbayashi T, Tanabe Y, Ito M, Takanashi J, Kohno Y, Shimizu T. Kubota H, et al. Sleep. 2003 Aug 1;26(5):555-7. doi: 10.1093/sleep/26.5.555. Sleep. 2003. PMID: 12938807
Similar articles
- Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH. Krahn LE, et al. Sleep. 2002 Nov 1;25(7):733-6. doi: 10.1093/sleep/25.7.733. Sleep. 2002. PMID: 12405608 - Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
Khatami R, Maret S, Werth E, Rétey J, Schmid D, Maly F, Tafti M, Bassetti CL. Khatami R, et al. Lancet. 2004 Apr 10;363(9416):1199-200. doi: 10.1016/S0140-6736(04)15951-5. Lancet. 2004. PMID: 15081654 - Hypocretin levels in sporadic and familial cases of canine narcolepsy.
Ripley B, Fujiki N, Okura M, Mignot E, Nishino S. Ripley B, et al. Neurobiol Dis. 2001 Jun;8(3):525-34. doi: 10.1006/nbdi.2001.0389. Neurobiol Dis. 2001. PMID: 11442359 - Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S, Kanbayashi T. Nishino S, et al. Sleep Med Rev. 2005 Aug;9(4):269-310. doi: 10.1016/j.smrv.2005.03.004. Sleep Med Rev. 2005. PMID: 16006155 Review. - Narcolepsy: a review of evidence for autoimmune diathesis.
Black JL 3rd. Black JL 3rd. Int Rev Psychiatry. 2005 Dec;17(6):461-9. doi: 10.1080/02646830500381492. Int Rev Psychiatry. 2005. PMID: 16401544 Review.
Cited by
- The economic consequences of narcolepsy.
Jennum P, Knudsen S, Kjellberg J. Jennum P, et al. J Clin Sleep Med. 2009 Jun 15;5(3):240-5. J Clin Sleep Med. 2009. PMID: 19960645 Free PMC article. - Status cataplecticus as initial presentation of late onset narcolepsy.
Panda S. Panda S. J Clin Sleep Med. 2014 Feb 15;10(2):207-9. doi: 10.5664/jcsm.3456. J Clin Sleep Med. 2014. PMID: 24533005 Free PMC article. - Orexin OX2 Receptor Antagonists as Sleep Aids.
Jacobson LH, Chen S, Mir S, Hoyer D. Jacobson LH, et al. Curr Top Behav Neurosci. 2017;33:105-136. doi: 10.1007/7854_2016_47. Curr Top Behav Neurosci. 2017. PMID: 27909987 Review. - Identification of the variations in the CPT1B and CHKB genes along with the HLA-DQB1*06:02 allele in Turkish narcolepsy patients and healthy persons.
Cingoz S, Agilkaya S, Oztura I, Eroglu S, Karadeniz D, Evlice A, Altungoz O, Yilmaz H, Baklan B. Cingoz S, et al. Genet Test Mol Biomarkers. 2014 Apr;18(4):261-8. doi: 10.1089/gtmb.2013.0391. Epub 2014 Feb 26. Genet Test Mol Biomarkers. 2014. PMID: 24571861 Free PMC article. - Hypnotics with novel modes of action.
Hoyer D, Allen A, Jacobson LH. Hoyer D, et al. Br J Clin Pharmacol. 2020 Feb;86(2):244-249. doi: 10.1111/bcp.14180. Epub 2020 Jan 17. Br J Clin Pharmacol. 2020. PMID: 31756268 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources